Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Jan 19, 2024

BUY
$255.51 - $362.11 $26,828 - $38,021
105 Added 14.46%
831 $236 Million
Q4 2021

Jan 19, 2024

BUY
$351.38 - $448.68 $255,101 - $325,741
726 New
726 $274 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cedrus LLC Portfolio

Follow Cedrus LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedrus LLC with notifications on news.